Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study-Reference-Cited by-同舟云学术

Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study

Published:2015-06-18 Issue:25 Volume:125 Page:3956-3962
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Wang Yu¹,Liu Qi-Fa²,Xu Lan-Ping¹,Liu Kai-Yan¹,Zhang Xiao-Hui¹,Ma Xiao³,Fan Zhi-Ping²,Wu De-Pei³,Huang Xiao-Jun¹⁴

Affiliation:

1. Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China;

2. Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China;

3. The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China; and

4. Peking-Tsinghua Center for Life Sciences, Beijing, China

Abstract

Key Points Haploidentical transplant achieves outcomes similar to those of identical-sibling transplant for AML patients in first remission. Haploidentical transplant is a valid postremission treatment of intermediate- or high-risk AML patients lacking an identical donor.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/125/25/3956/1386704/3956.pdf

Reference38 articles.

1. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.;Döhner;Blood,2010

3. Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?;Cornelissen;Blood,2007

4. Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A.;Schlenk;J Clin Oncol,2010

5. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.;Koreth;JAMA,2009

Cited by 344 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplantation for Patients with Hodgkin Lymphoma: A Comparative Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation;Transplantation and Cellular Therapy;2024-02

2. Myeloablative Haploidentical Donor Hematopoietic Transplantation Using Post-Transplantation Cyclophosphamide and Antithymocyte Globulin;Transplantation and Cellular Therapy;2024-01

3. The Proportion of Myeloid-derived Suppressor Cells in the Graft as a Potential Predictor of Acute Graft-versus-host Disease in Haploid Allogeneic Hematopoietic Stem Cell Transplantation;Journal of Immunotherapy;2023-12-12

4. Outcomes of haploidentical hematopoietic stem cell transplantation with ‘Beijing protocol’ in pediatric myeloid neoplasms post cytotoxic therapy: a case series study;Leukemia & Lymphoma;2023-12-03

5. Prognostic Factors and Outcomes in Patients With Septic Shock After Allogeneic Hematopoietic Stem Cell Transplantation;Transplantation and Cellular Therapy;2023-12